Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The company says it is enrolling patients in standard-of-care chemotherapy combination cohorts in its global Phase 1/2 ASCEND trial and has initiated additional ADC combination studies. More than 125 patients have been dosed, and dose escalation is complete.
Patients are enrolling in standard-of-care chemotherapy combination cohorts of the global Phase 1/2 ASCEND trial; additional ADC combination studies with CR-001 have begun.